Pharmacological inhibition of this pathway restored DS iPSC-derived IN migration in vitro, suggesting a causal relation between PAK1 pathway dysregulation and migration defects (Huo et al., 2018). The gene discussed is PAK1; the disease is Dravet syndrome.